ArticleOncology letters2018

Inhibitor of DNA binding 3 reverses cisplatin resistance in human lung adenocarcinoma cells by regulating the PI3K/Akt pathway.

Fang-Fang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.